Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types (2)
Select products & services
Select solutions
Active Filters (2)
Clear All
1 - 12 of 169 Results
Sort by:
Best Match
Scientific Poster
One-step engineering of allogeneic cell therapies with Pin-point base editing platform and an AI-engineered Cas enzyme
This scientific poster describes a one-step process to engineer allogeneic cell therapies with the Pin-point base editing platform and an AI-engineered Cas enzyme.
Scientific Poster
Illuminating the path to innovation: Revvity's high content screening services
This scientific poster presented at ELRIG Drug Discovery introduces Revvity's preclinical high content imaging services.
Scientific Poster
A versatile base editing technology with broad Cas enzyme and deaminase compatibility well suited for Cell and Gene Therapy
This scientific poster describes the development of a versatile base editing platform for cell and gene therapy.
Webinar
End-to-end solutions for Companion Diagnostics (CDx): From assay development to regulatory affairs
Revvity Omics end-to-end solutions for Companion Diagnostics (CDx). Learn about assay development, regulatory affairs, and more.
Scientific Poster
Novel optical 2D image acquisition and analysis of tumor metastasis using the MVI-2 two-mouse, 360-degree positioning device
This scientific poster highlights 2D optical image acquisition and analysis of tumor metastasis using the MVI-2 multi-viewer 2 mouse, 360-degree positioning device.
Webinar
wbs-adc-for-cancer-therapy
Explore and learn about the successes and advancements in ADCs with learnings from the clinic presented by industry experts from AstraZeneca and AbbVie
Scientific Poster
Development of a Hemolysis Index for Vanadis® cfDNA NIPT Sample Acceptance
Investigating samples that are below 1% hemolysis does not affect the accuracy of Vanadis® cfDNA NIPT results. Either spectrophotometry or a color comparison chart can be used to preferentially remove those samples that are highly hemolyzed from the workflow.
Scientific Poster
Importance of parental segregation studies and its role in variant classification
This poster highlights importance of parental segregation. Analysis helps to verify the phasing of the causative variants, to verify the de novo occurrences thereby aiding reclassification of the reported variants. Parental analysis post proband testing to better understand complex genetic variations.
Scientific Poster
Genetic Screening of a Reportedly Healthy Population for Familial Hypercholesterolemia, Hereditary Breast and Ovarian cancer syndrome, and Lynch syndrome
This poster highlights the benefits of healthy population screening for the conditions like Familial Hypercholesterolemia, Hereditary Breast and Ovarian cancer syndrome, and Lynch syndrome
Scientific Poster
Unparalleled power of genome sequencing in screening ostensibly healthy newborns and children: findings from the first real-world dataset
This poster concludes that ostensibly healthy babies are at-risk for pediatric onset mendelian condition. Majority of the GS findings are likely to influence healthcare management of babies at risk, and provide valuable information for other family members.
Scientific Poster
Evidence of Complex Inheritance Patterns in Limb-Girdle and other Muscular Dystrophies: Synergistic Heterozygosity and Multigenic Inheritance
This poster highlighted a high prevalence of patients with pathogenic variants in more than one MD gene suggesting possible multigenic contribution to disease presentation that needs consideration as a part of diagnostic modality. It indicated the importance of further genotype-phenotype correlation studies in other family members to completely understand the complex inheritance mechanism involved in the different muscular dystrophy subtypes
Scientific Poster
Limb-Girdle Muscular Dystrophy and other Myopathy Patients Diagnostic Yield in Large Cohort of more than 6000 patients
NGS panel study greatly helped to identify LGMD subtypes as well as other myopathies with clinical features overlapping with LGMD subtypes. Increased prevalence was observed for genetically confirmed Oculopharyngeal Muscular Dystrophy (OPMD), VCP related inclusion body myopathy, and other dominant overlapping MDs.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.